- All sections
- C - Chemistrymetallurgy
- C07H - Sugarsderivatives thereofnucleosidesnucleotidesnucleic acids
- C07H 19/14 - Pyrrolo-pyrimidine radicals
Patent holdings for IPC class C07H 19/14
Total number of patents in this class: 248
10-year publication summary
23
|
31
|
16
|
41
|
29
|
22
|
33
|
23
|
18
|
1
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Illumina Cambridge Limited | 675 |
31 |
Prelude Therapeutics, Incorporated | 124 |
13 |
The Trustees of Columbia University in the City of New York | 3546 |
12 |
Singular Genomics Systems, Inc. | 275 |
12 |
Chimerix, Inc. | 86 |
9 |
Merck Sharp & Dohme LLC | 3722 |
9 |
Arcus Biosciences, Inc. | 130 |
8 |
IsoPlexis Corporation | 116 |
7 |
Agilent Technologies, Inc. | 2642 |
6 |
The Regents of the University of Michigan | 4619 |
6 |
Gilead Sciences, Inc. | 2006 |
6 |
Merck Sharp & Dohme Corp. | 2202 |
5 |
Roche Sequencing Solutions, Inc. | 624 |
5 |
Epizyme, Inc. | 367 |
4 |
Taisho Pharmaceutical Co., Ltd. | 855 |
4 |
Emory University | 1609 |
3 |
Institute of Organic Chemistry and Biochemistry ASCR,V.V.I. | 37 |
3 |
Quantumdx Group Limited | 55 |
3 |
Southern Research Institute | 210 |
3 |
Novartis AG | 11039 |
2 |
Other owners | 97 |